Katherin Patsch, PhD, is a Senior Project Manager, Translational Research at the Ellison Institute. She is working across research teams to develop a cancer drug discovery pipeline that supports innovative early discovery, mechanistic studies, and translational biology, to address unmet clinical needs.
The Ellison Institute addresses pressing challenges in cancer care through rigorous and rapid deployment of novel technologies to enhance clinical practice, diagnostics, and research. Along these lines, Katherin has developed a series of projects with select MPS technologies with the goal of enabling use in discovery and pre-clinical testing.
Dr. Patsch received her PhD in Molecular and Cell Biology from the Medical University of Innsbruck in Tyrol, Austria, where she studied cell signaling in regenerating muscle. In 2012, she joined USC/Ellison Institute to study androgen receptor dynamics using novel bi-directional functional assays. Her findings ultimately helped launch the Institute’s first drug discovery project.
The Ellison Institute addresses pressing challenges in cancer care through rigorous and rapid deployment of novel technologies to enhance clinical practice, diagnostics, and research. Along these lines, Katherin has developed a series of projects with select MPS technologies with the goal of enabling use in discovery and pre-clinical testing.
Dr. Patsch received her PhD in Molecular and Cell Biology from the Medical University of Innsbruck in Tyrol, Austria, where she studied cell signaling in regenerating muscle. In 2012, she joined USC/Ellison Institute to study androgen receptor dynamics using novel bi-directional functional assays. Her findings ultimately helped launch the Institute’s first drug discovery project.